Management of Major Bleeding Events in Patients Treated With Rivaroxaban Versus Warfarin: Results From the ROCKET AF Trial

被引：0

作者：

Piccini, Jonathan P. ^{[1
]}

Garg, Jyotsna ^{[2
]}

Patel, Manesh R. ^{[1
]}

Lokhnygina, Yuliya ^{[3
]}

Goodman, Shaun G. ^{[4
,5
]}

Becker, Richard C. ^{[1
]}

Berkowitz, Scott D. ^{[6
]}

Breithardt, Gunter ^{[7
]}

Hacke, Werner ^{[8
]}

Halperin, Jonathan L. ^{[9
]}

Hankey, Graeme I. ^{[10
,11
]}

Nessel, Christopher C. ^{[12
]}

Mahaffey, Kenneth W. ^{[1
]}

Singer, Daniel E. ^{[13
,14
]}

Califf, Robert M. ^{[15
]}

Fox, Keith A. ^{[16
,17
]}

机构：

[1] Duke Clin Rsch Inst, Dept Med, Div Cardiol, Durham, NC USA

[2] Duke Clin Rsch Inst, Stat Grp, Durham, NC USA

[3] Duke Clin Rsch Inst, Dept Biostat & Bioinformat, Durham, NC USA

[4] Univ Toronto, St Michaels Hosp, Canadian Heart Rsch Cntr, Toronto, ON, Canada

[5] Terrence Donnelly Heart Cntr, Toronto, ON, Canada

[6] Bayer HealthCare Pharmaceut, Global Therapeut Rsch, Cardiovasc Pharmacol, Montville, NJ USA

[7] Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany

[8] Heidelberg Univ, Dept Neurol, Heidelberg, Germany

[9] Mt Sinai, Icahn Sch Med, Mt Sinai Med Cntr, Cardiovasc Inst, New York, NY USA

[10] Univ Western Australia, Sch Med & Pharmacol, Dept Neurol, Perth, WA 6009, Australia

[11] Royal Perth Hosp, Stroke Unit, Perth, WA 6001, Australia

[12] Janssen Rsch & Dev, Clin Rsch, Raritan, NJ USA

[13] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[14] Harvard Univ, Sch Med, Boston, MA USA

[15] Duke Translat Med Inst, Dept Med, Div Cardiol, Durham, NC USA

[16] Univ Edinburgh, Cntr Cardiovasc Sci, Edinburgh, Midlothian, Scotland

[17] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

来源：

CIRCULATION | 2013年 / 128卷 / 22期

关键词：

Atrial fibrillation; Stroke; Risk factors;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

15879

引用

页数：2

共 50 条

[1] Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
Piccini, Jonathan P.
Garg, Jyotsna
Patel, Manesh R.
Lokhnygina, Yuliya
Goodman, Shaun G.
Becker, Richard C.
Berkowitz, Scott D.
Breithardt, Guenter
Hacke, Werner
Halperin, Jonathan L.
Hankey, Graeme J.
Nessel, Christopher C.
Mahaffey, Kenneth W.
Singer, Daniel E.
Califf, Robert M.
Fox, Keith A. A.
EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1873 - 1880
[2] Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin ROCKET AF Trial
Sherwood, Matthew W.
Nessel, Christopher C.
Hellkamp, Anne S.
Mahaffey, Kenneth W.
Piccini, Jonathan P.
Suh, Eun-Young
Becker, Richard C.
Singer, Daniel E.
Halperin, Jonathan L.
Hankey, Graeme J.
Berkowitz, Scott D.
Fox, Keith A. A.
Patel, Manesh R.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (21) : 2271 - 2281
[3] Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke: Results From the ROCKET AF Trial
Piccini, Jonathan P.
Hellkamp, Anne S.
Mahaffey, Kenneth W.
Berkowitz, Scott D.
Nessel, Christopher C.
Becker, Richard C.
Halperin, Jonathan L.
Hacke, Werner
Singer, Daniel E.
Hankey, Graeme J.
Breithardt, Guenter
Fox, Keith A.
Califf, Robert M.
Patel, Manesh R.
CIRCULATION, 2014, 130
[4] Outcomes of rivaroxaban versus warfarin in women and men with nonvalvular atrial fibrillation: results from the ROCKET AF trial
Dixon, B.
Hellkamp, A. S.
Lokhnygina, Y.
Piccini, J. P.
Berkowitz, S. D.
Mahaffey, K. W.
Becker, R. C.
Breithardt, G.
Fox, K. A. A.
Patel, M. R.
EUROPEAN HEART JOURNAL, 2015, 36 : 744 - 744
[5] OBESITY PARADOX FOR STROKE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL
Balla, Somasekhara R.
Cyr, Derek
Lokhnygina, Yuliya
Becker, Richard
Berkowitz, Scott
Breithardt, Guenter
Califf, Robert
Fox, Keith
Hacke, Werner
Halperin, Jonathan
Hankey, Graeme
Mahaffey, Kenneth
Nessel, Christopher
Piccini, Jonathan
Singer, Daniel
Patel, Manesh
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A371 - A371
[6] Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
Piccini, Jonathan P.
Stevens, Susanna R.
Lokhnygina, Yuliya
Patel, Manesh R.
Halperin, Jonathan L.
Singer, Daniel E.
Hankey, Graeme J.
Hacke, Werner
Becker, Richard C.
Nessel, Christopher C.
Mahaffey, Kenneth W.
Fox, Keith A. A.
Califf, Robert M.
Breithardt, Guenter
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (19) : 1998 - 2006
[7] Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial
Piccini, Jonathan P.
Stevens, Susanna
Lokhnygina, Yuliya
Patel, Manesh
Singer, Daniel
Halperin, Jonathan
Hankey, Graeme
Hacke, Werner
Becker, Richard
Nessel, Christopher
Mahaffey, Kenneth
Fox, Keith
Califf, Robert
Breithardt, Gunter
CIRCULATION, 2012, 126 (21)
[8] Reply to letter by Bamford et al. regarding the article: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKETAF trial
Piccini, Jonathan P.
Garg, Jyotsna
Hellkamp, Anne
Pieper, Karen S.
Patel, Manesh R.
EUROPEAN HEART JOURNAL, 2019, 40 (19) : 1568 - 1568
[9] Rivaroxaban versus warfarin: results of the ROCKET study
Judit, Liptak
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2012, 65 (9-10): : 349 - 351
[10] Efficacy and Safety of Rivaroxaban versus Warfarin in Patients Taking Non-dihydropyridine Calcium Channel Blockers: Results From the ROCKET AF Trial
Washam, Jeffrey B.
Hellkamp, Anne S.
Lokhnygina, Yuliya
Piccini, Jonathan P.
Berkowitz, Scott D.
Nessel, Christopher C.
Becker, Richard C.
Breithardt, Guenter
Fox, Keith A.
Halperin, Jonathan L.
Hankey, Graeme J.
Mahaffey, Kenneth W.
Singer, Daniel E.
Patel, Manesh R.
CIRCULATION, 2015, 132

← 1 2 3 4 5 →